Login / Signup

Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.

Asmaa A AshourAmal Hassan El-KamelDoaa A AbdelmonsifHoda M KhalifaAlyaa A Ramadan
Published in: International journal of nanomedicine (2021)
The modified TSIIA-LNCs could be regarded as promising novel targeted nanomedicines for effective management of liver fibrosis.
Keyphrases
  • liver fibrosis
  • cancer therapy
  • fatty acid
  • drug delivery